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This paper introduces a systematic approach to organizing the
discipline ofclinical chemistry. The approach is called a top-down,
systems approach because it starts at the top with the most general
concepls and works down through less general concepts to the most
specijic details and techniques. The hypothesis is that the discipline
can be organized into hierarchical levels offunctional processes and
operational approaches to those process.es. Thefunctional processes
represen! what clinical scientists do; the operatinal approaches
represent how they do it. Becausefunctional proesses change little,
if at all, with time, they are used to develop a stable infrastructure
or’amework for the discipline. That infrastructure is then used
to organize and understand operational approaches that tend to
change rapidly with tine in response to technological advances.
The paper begins with the most general functional processes and
then uses selected examples ofthe more generalfunctions to illustrate
lower hierarchical levels orfunctional processes and operational
approaches.
Introduction
During this century clinical chemistry has evolved
from a modest collection of routine tests to a complex and
sophisticated science [1]. The needs of the medical
community and the scientific and technological advances
in the discipline have become increasingly diverse and
complex [2]. The benefits which have resulted from this
process are, of course, accompanied by some problems.
The profissional roles of clinical scientists have become
increasingly diverse. They include complex managerial
responsibilities and maintenance of research programmes,
consultation with physicians, catalysing commerical
developments and evaluating new approaches to clinical
instrumentation, reagent systems and procedures, as well
educating clinical scientists and medical studients. In
addition to being responsible tbr laboratory services and
providing consultation to medical personnel, they must
oversee maintenance of good laboratory practices related
to quality assurance and safety of laboratory personnel.
These changes in the professional responsibilities ofclinical
scientists have been accompanied by an expanding base
of knowledge and technological advances that must be
mastered. Advances are being made in many diverse
areas, such as the chemical (immunodiagnostics and DNA
probes), instrumental (microelectronics, sensors, robotics,
computers), mathematical tools (chemometrics, artificial
intelligence), etc. [2]. As clinical instruments have evolved
from relatively simple manual devices [1-] to highly-
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integrated, self-contained systems involving increasingly
complex technologies [2], it has become increasingly
difficult to identify and understand the internal functions
of the systems. It has become much easier to treat these
systems as black boxes, with emphasis shifted from the
internal functions to external features, such as operational
characteristics, throughput rates, precision, cost per test,
etc.
These and other related challenges will become more
severe as increasingly complex technologies are used to
solve increasingly complex problems. The challenges will
be compounded as such tools as robotics and artificial
intelligence are used to integrate more of the analytical
and diagnostic processes into self-contained systems. The
best way for clinical scientists, their students, and their
clients to meet these challenges is to develop and use a
more systematic approach to the discipline of clinical
chemistry than in the past.
The purpose of this paper is to introduce a highly
structured approach to the discipline. This is called a
top-down, systematic approach to clinical chemistry because
topics are organized into a systematic pattern that begins at
the top with the most general concepts and works down through
less general concepts to techniques and operational details with
decreasing degrees ofgenerality. The heart of the approach is
a general framework, or infrastructure, for the discipline
that changes very little, ifat all, with time. This framework
is used to organize and understand those parts of the
discipline, such as different technologies [2], that do
change with time.
Rationale
The primary rationale for this proposal is that the many
different aspects of this or any other scientific discipline
can be grouped into two general categories, namely
functional processes and operational approaches. Simply stated,
functional processes represent what we do and operational
approaches represent the ways we do it. For example, a
separation in a chemical determination is afunctionalprocess;
it isolates one or more components in a sample from other
components that might interfere with some other part of
the process, such as the measurement step. On the other
hand, precipitation/filtration, liquid-liquid extraction, dialysis,
liquid chromatography, gas chromatography, electrophoresis, etc.
are all examples ofoperational approaches to the separation process.
In other words, a separation is a general process and the
different types of separations represent the specific ways
we implement this process. Other examples of functional
processes include sampling, sample identification, sample
processing, measurement and data-processing.
Functional processes form the general infrastructure of
clinical chemistry. These processes tend to change very
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little with time. On the other hand, operational approaches
to these functions tend to be in a state of constant flux;
they change with time, with technological advances and
with different requirements ofinstrument systems, clinical
procedures, clients’ needs, market pressures, etc. It follows
that functional processes represent a stable framework that
can be used to organize and understand the more transient
operational approaches and technological developments
[2]. Accordingly, this paper starts with a discussion of
functional processes in clinical chemistry.
Functional processes
Functional processes can be grouped into hierarchical
levels, with the highest levels being the most general and
the lowest levels being the least general. Here we discuss
examples from each offour hierarchical levels offunctional
processes in clinical chemistry.
Highest level
The goal here is to identitk/ the smallest number of
functions required to encompass all the professional
activities of clinical chemists. The group should not
contain any redundancies, but should be sufficiently
complete that any function not included can be grouped
under one of the functions included in the group.
As shown in figure 1, five functions are both necessary
and sufficient to satisfy these criteria. Considered in its
most general and positive context, service is of course the
primary function of the discipline, as it is with all other
professions. The service function is provided through
medical personnel to patients in and out of hospitals, to
health maintenance programmes and in a variety ofother
FUNCTIONALCOMPONENTS
OF
CLINICALCHEMISTRY
Figure 1. Highest level of functional components in clinical
chemistry.
forms. The service function is made possible by the other
four functions of research, development, education and manage-
ment.
It is not always possible to distinguish clearly among these
functions, just as it is not always easy to distinguish clearly
among different scientific disciplines. For example, in the
extreme, the service function could be viewed to include
other functions such as research, ,development and
education. In other situations, it is difficult to distinguish
clearly between research and development functions
because these activities are frequently very closely related
to one another. However, despite these areas of overlap,
the meaning of each of these functions is .sufficiently well
understood to make them useful in a systematic .organiza-
tion of this or other disciplines.
Second level (service function)
Each of the functions in figure could be subdivided into
hierarchical sublevels. However, it is beyond the scope of
this paper to attempt this for all these processes. Rather,
the focus is on just one, namely the service thnction.
Some may believe that the primary function of a clinical
laboratory is to generate data for samples delivered to it.
However, that is just one part of the service function in
clinical chemistry. As shown in figure 2, the service
function is part of a process in which the primary focus
is a patient or other subject--the diagnosis and prognosis
SERVICE FUNCTION
FORMATIO
ORMULAT RESULTS/
kDIAGNOSIS; ( PATIENT /
.’ONCLUSION5
/,.---- .-
/ TEST X -"" DETER- DIAGNOSIS .’" MINATION
QUALITY
NEEDED FORMULATE EDUCATION
Figure 2. Example second level funclional components, service
function. (--), primary responsibili of medical personnel;
), prima responsibili of laboratou personnel.
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of a patient’s problem is a cyclic process involving interactions
among medical and laboratory personnel.
The process begins when a patient’s problem is identified.
The first steps in the process are to assimilate available
information, formulate an initial diagnosis, test the
diagnosis to determine if additional information is needed
to confirm it, and, if so, to identify what additional
information is needed. If chemical information is needed,
then it is necessary to formulate a plan to obtain the
needed information, do the necessary chemical determina-
tions and assimilate the new information with that already
available and to use it to test initial diagnoses and
tbrmulate new ones if necessary. For all but the simplest
cases, this cyclic process will often be repeated several
times to reach a final diagnosis and monitor the progress
of a patient.
An important question is how,. and by whom,, the various
components of the service functions in figure 2 should be
handled to best serve the interests of the patient. Given
the different types of expertise required to identify,
determine, interpret and use laboratory results, the
interests of the patient would be served best in most cases
by an interactive process among medical and laboratory
personnel. Although medical personnel probably should
have primary responsibility for the functions in dashed
circles in figure 2, and laboratory scientists should have
primary responsibility for functions in solid circles, the
interests of the patient will be served best if laboratory
scientists (for example clinical chemists) are involved in
all parts of the process for all but the simplest cases. If
given sufficient information, well-qualified laboratory
scientists have the background and expertise to recognize
diagnostic cut-off levels or decision points, to formulate
and test tentative diagnosises, and to identify additional
intbrmation that will be helpful in confirming or refuting
them. As indicated by the dashed arrows near the bottom.
of figure 2, the interests of the patient would be served
best by an organization in which clinical scientists are
given sufficient information and authority to test diagnoses
and either report that the diagnoses are confirmed or
obtain additional information if it is needed. This would
significantly accelerate the diagnostic process by reducing
delays between the time when results are obtained and
interpreted. Artificial intelligence and expert systems
could, be used effectively to aid in the interpretations.
Regarding the laboratory functions themselves, for
situations in which routine procedures have been devel-
oped, then the planning process may involve operational
issues, such as assigning technical personnel and fitting
the requested determinations into laboratory work
schedules. However, tbr any procedure to become routine,
significant amounts of advance planning must have been
done. For well-established determinations, this may
involve selection of appropriate procedures, reagents,
instrumentation, personnel and setting up appropriate
laboratory protocols. However, regardless of how estab-
lished any procedure may appear, at some point in time
it was not thlly understood or implemented efficiently and.
substantial amounts of research, development and educa-
tion were necessary before it could be treated as a routine
procedure. Therefore, even though these features of the
planning process may not be apparent in the day-to-day
operation of a laboratory, their importance must not be
overlooked if the newer concepts of today are to be made
available as the routine procedures of tomorrow. It is
ironic that the more efficient the laboratory process
becomes, the less apparent the significance ofthe planning
stage is to clients of the service.
The focus of this discussion is analytical systems, so the
determination tanction has been chosen as the third level.
The following treatment of the determination function
will hopefully inspire those with interests in other parts
ofthe service function to develop them in a systematic way.
Third level (quantitative determination)
The determination function in figure 3 is used here to
illustrate a third level of functional processes, because this
is one of the primary functions of the clinical laboratory.
It is important, before discussing the functional parts of
a determination, that readers note that issues such as
biosafety and quality assurance must be kept in mind and
acted upon throughout the process.
An important question for this paper is: what is the
minimum number of non-redundant functional processes
that can be used to represent all the types of operations
in chemical determinations? As shown in figure 3, six
different types of functional processes are necessary and
sufficient to represent all the different types of processes
in any type of chemical determination. These processes
will not proceed in any particular order nor will all types
of processes be included in all types of determinations,
although most will be included in most determinations.
All determinations must begin with a sampling step. If a
sample is physically removed from the system of interest,
CLINICAL DETERMINATION
QUALITY
ASSURANCE
Figure 3. Example of third level of functional processes,
determination function.
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then some type of sample identification will be required. In
most instances, some type of sample processing will also be
needed. The sample-processing function includes such
steps as addition of an anticoagulant or removal of a clot,
as well as many other types of processes discussed in the
next section. The thnction of this step is to prepare the
sample for the measurement function, during which some
chemical or physicalproperty is measured. After an appropriate
signal is measured, then there will usualy be some type
of data processing required to convert measured signals to
the desired intbrmation (tbr example analyte concentra-
tion or activity). The process is completed by a reporting
step, in which results are conveyed in an appropriate
format to the client requesting the information.
Contrary to popular usage, the sampling step is a critical
parl of every determination. Regardless of how carefully a
sample or sample aliquot is handled after a sample is
obtained,/of the sampling process isflawed the determination will
bejqawed. Because it is critical that everyone associated
with the sampling process understands this, this paper
suggests usages which state that determinations are done
on the system ofinterest (patients or other subjects), rather
than on samples.
Fourlh level (sample processing)
The sample processing function in figure 3 has been
selected to illustrate a tburth level of functional processes.
Figure 4 illustrates five thnctions that can be used to
describe most it" not all of the different types of sample
processing operations. These functions are sample transport,
physical changes, chemical changes, mixing and separation.
It’a sample is withdrawn from the system of interest (a
patient or other subject), then it will be necessary to
SAMPLE PROCESSING
Figure 4. Example of.fourth level oj’functional processes,
sample-processing junction.
transport the sample to different locations, where the other
types of operations can be done on it. These ’other types
ofoperations’ can include physical and chemical changes.
Physical changes include changes of state and changes of
physical properties, such as temperature, pressure and
colour. Chemical changes include a wide variety of types of
reactions, such as simple acid/base reactions, precipitation
and coagulation reactions, enzymatic reactions, immuno-
chemical reactions, polymerase chain reactions (PCRs)
for DNA species etc. In other words, all types of chemical
processes are included under the heading of chemical
changes.
Mixing is, of course, necessary to implement many
different types of chemical and physical processes.
Separations take many forms such as precipitation/filtra-
tion, dialysis, liquid-liquid extraction, many forms of
chromatography, electrophoresis, capillary zone electro-
phoresis (CZE) and separations based on mass-to-charge
ratios as in mass spectrometry etc. Again, all types of
separation processes would be included under this
heading.
Strictly speaking, mixing and separation are physical
processes and could be included as a fifth level of
functional processes. However, these processes are so
prominent in so many different types of determinations
that they merit inclusion at this level.
Many processes, such as precipitation, are neither strictly
chemical nor strictly physical in nature. Another category,
called physico-chemical changes, could be added to figure
4. However, regardless ofhow interrelated these processes
may appear, they can all be separated into chemical
processes and physical processes. Although a separate
function for physico-chemical processes is not included in
figure 4, it is convenient to use this term for processes that
include both chemical and physical components.
Other types of functional processes in figures 1-3 could
be treated in a manner similar that presented above for
the service, determination and sample-processing func-
tions. However, the goal of this paper is not a comprehen-
sive treatment, but, rather, an illustration of the pro-
posal for a systematic approach to clinical chemistry.
Accordingly, attention is now turned to operational
approaches to some of the functions described above.
Operational approaches
Operational approaches represent the different ways
thnctional processes are implemented. Very large text-
books would be required to describe all the operational
approaches to the functions in figures 3 and 4. Accord-
ingly, it would be hopeless to attempt a comprehensive
treatment in this paper. Theretbre, what is done here is
to use selected examples to illustrate how a more
comprehensive treatment could be organized in a syste-
matic way.
Sampling function
Figure 5 illustrates several issues that are important in
the design or selection of an overall approach to the
sampling thnction. The left-hand column in the figure
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SAMPLING FUNCTIONI
Feature Options
Domain
Location
Frequency
Mode 1
Mode 2
Other ?
continuous
Localized
Continuous
Invasive Non-
invasive
Destructive destructive
9 9
Figure 5. Higher level operational approaches to the sampling
funclion.
identifies the major issues considered here. The circles on
the right side of the figure identify two distinctly different
subclassifiers for each ofthe major issues. The solid vertical
and diagonal arrows identify the many different ways that
these different options can be combined. Any option can
be combined with any other option above or below it on
either side of the figure; the only restriction is that no
option can be combined with the one directly across
from it.
One of the first issues that must be considered in designing
a sampling procedure is what part of the system is to be
sampled; this is termed the sampling domain. In clinical
chemistry the syslem of interest is usually the human body
or some part of it. However the system is defined (the
body as a whole, the venous or arterial blood supply, a
particular organ), there are just two choices for selecting
the sampling domain. Those choices are to select the
sampling domain to represent a bulk property of the entire
system or a localizedproperty ofa specific part of the system..
If the ’system’ is defined as a particular organ, then a
bulk property would be a property of the organ as a whole
and a localized property would be a property of a specific
part of the organ.
A second important issue is the sampling location. Again,
there are just two choices: to process the sample inside
the system (intra-system sampling); or to remove the
sample from the system (extra-system sampling). In most
clinical applications, samples (blood, urine, amniotic
fluid) are physically removed from the patient. However,
there are situations in which the sampling process takes
place inside the patients. This is the case for methods such
as X-ray, nuclear magnetic resonance (NMR), reflectance
methods for bilirubin, microdialysis etc.; it would be the
case if selective sensors were implanted in patients. In
other words, the sampling process does not necessarily
involve physical removal of a sample from the system of
interest, although that is usually the case for most
present-day methodologies.
The third important issue is the samplingfrequency, i.e. how
often samples are collected. There are two general options:
to sample the system continuously (continuous sampling);
or to sample the system at selected time intervals
(discontinuous sampling). Usually sampling is discon-
tinuous in chemical applications; however, with some
approaches, such as implanted sensors, it could be
continuous.
Other important considerations are whether the sampling
process is invasive or noninvasive, and whether it is destructive
or non-destructive. For lack of better terms, these options
have been identified as sampling mode 1 and sampling mode
2. However these issues are identified, these binary choices
impose distinctly different and unique characteristics on
the sampling process.
It might appear at first glance that there is redundancy
between the sampling location and mode options, i.e.
it might appear that intra-system sampling is invasive and
extra system sampling is non-invasive. However, this is
not necessarily the case. For example collection of blood
and urine samples are both extra-system approaches.
However, although use of a syringe needle to collect a
blood sample is invasive, collection of a urine sample is
usually non-invasive. Analogously, intra-system sampling
by implanting a sensor is invasive, whereas intra-system
sampling by methods such as X-ray, NMR and reflectance
measurements are not physically invasive.
Most of the sampling approaches in current use are
destructive. For example, when a blood sample is with-
drawn and processed in the laboratory, that is destructive.
This may not be significant to an adult with a large supply
of blood, but it could be very significant for an infant
with a limited supply of blood.
The overall characteristics of a sampling procedure will
depend upon how the different options for these and other
issues are combined. As noted above, the arrows in
figure 5 (and other similar figures in this section) indicate
that options represented by most subclassifiers can be
utilized with options represented by subclassifiers above
and below them (vertical arrows) and on either side of
the figures (diagonal arrows). For example, consider a
path from a localized property to intra-system sampling
to continuous sampling to invasive and non-destructive
sampling modes. This pathway could represent the use of
an implanted sensor to monitor some property (for
example analyte concentration or activity) of a particular
organ continuously without damaging the organ. Many
other such paths could be traced to design other sampling
procedures with different characteristics; the primary
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restriction is that no option can be used with the one
directly across from it. Similar considerations apply for
figures 6-8 that are discussed in the followed subsections.
Sample-transportfunction
Figure 6 illustrates several issues that should be considered
in developing or selecting a sample-transport system. The first
issue listed is implementation, namely whether the system
is manual or automated. There are very few, if any,
systems that are completely automated in the sense that
all aspects of sample transport are automated from the
point where it is withdrawn from a patient until a final
result is obtained. The first parts automated were the
processes after samples reached the laboratory. More
recently, robots are being used to automate the transport
of samples to the laboratory [3]. However, even the most
recent systems still involve some manual steps to get the
samples to the robots.
[SAMPLE TRANSPORT FUNCTION]
Feature Options
lmplementation
Phase
Interactions
Sample
Sequence
Access
Analyte
S,clectipn,
Processing[ Mode
Figure 6. Higher level operational approaches to the sample-
transport function.
The second issue involves the transport mode; the two
approaches developed to date are discrete systems and
flow systems. The third issue involves phase interactions;
that is, whether samples are or are not in segmented phases.
A primary feature of discrete-sample transport systems is
that they keep samples in segmented phases, usually in
individual containers; flow systems have been developed
with and without segmented phases. Examples include
the flow system developed by Skeggs [4-] and the more
recently developed approach identified as flow-injection
systems [5].
Sample sequence, sample access and analyte selection are
important issues. Samples can be sequenced either in series
or in parallel. Most early sample-transport systems
processed samples in series; more recent systems tend
toward parallel processing. The question of access refers
to whether samples are processed in a fixed sequence,
depending on the order in which they are placed in the
system, or whether the sequence can be altered with time.
This latter feature is sometimes called ’random access’
by analogy with computer memory. However, careful
consideration of the meaning of the word ’random’
(without choice or plan) shows that this term does not
convey the intended meaning. Fixed-sequenc.e’ and
’variable-sequence’ are more valid terms.
Analyte selection can vary from a single component
(sometimes called ’batch’) to multiple components
(sometimes called ’profile’). Although the latter term
(profile) probably is satisfactory for the intended meaning,
the former (batch) conveys an entirely different concept.
Specifically, one could do multicomponent determina-
tions (profiles) simultaneously on a batch (collection) of
samples.
The final issue mentioned is the processing mode, that is
whether samples are moved discontinuously (stepwise) or
continuously through the system. An example would be
continuous-flow versus stopped-flow systems, although the
concept applies equally well to discrete systems. Dis-
continuous operation offers more flexibility in timing
sequences for different parts of the total process than does
continuous operation. Discontinuous systems are advan-
tageous for .slow reactions, physical processes etc.
There probably are other issues that could be considered,
but these are sufficient to illustrate the concept which is
the primary goal of this paper.
In discussing the issues related to the sample-transport
function this paper has not distinguished between, or
focused on, features unique to any particular functional
process in figure 4. The reason is that issues and choices
represented in figure 6 .are all relevant to all the processes
in figure 4. In other words, these issues and options are
just as relevant to separation methods, such as liquid-
liquid extraction, chromatography and electrophoresis, as
they are to the so-called ’clinical analysers’ used in clinical
laboratories. For example, liquid-liquid extraction is
usually .done in a discrete, segmented mode., while
chromatography is usually done in a continuous-flow,
unsegmented mode. Ion-exchange separations have been
.done in both discrete and flow modes, with and without
segmentation. This is the beauty of the systems approach;
it provides a unifying theme to many different aspects of
the discripline that too often are considered as completely
separate and unrelated ’techniques’.
Measurement function
The measurement function is considered in more detail
than the other functions in order to illustrate some
different levels of operational ,approaches. First, some of
the more general issues are discussed, then some less
general options are considered.
222H. L. Pardue et al. Systematic top-down approach to clinical chemistry
First level
Figure 7 shows several of the more general issues involved
in the measurement function. The first issue considered
is the time of the measurement; that is whether the
measurement is a kinetic-based or an equilibrium-based
method. As illustrated in figures 3 and 4, different types
of processes can influence the measurement step. In fact,
any of the types of processes in figures 3 and 4 can impose
transient (kinetic) character on the measured signal.
There is a tendency to focus more on kinetic aspects of
chemical reactions than physical or physico-chemical
processes. However, any or all ofthese processes, including
the measurement system itself, can impose kinetic charac-
ter on a measured signal. A measurement approach will
have kinetic character if any process that influences the
measured signal has not reached equilibrium when the
measurement, or any part of it, is made. A measurement
approach may or may not be an equilibrium-based
method if all processes that influence the measurement
have reached equilibrium when the measurement is made.
An example of an exception would be a case in which the
measured response is the time required for a process to
reach equilibrium; although an equilibrium signal would
be measured, the overal, procedure would represent a
kinetic-based method because the result would depend on
the rate at which the process approached equilibrium.
[MEASUREMENT FUNCTION[
Feature Options
Time
Type of Chemical Process
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Objective
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9
Figure 7. Higher level operational approaches to the measurement
function.
The types of processes used can be either chemical, physical
or some combination ofphysic0-chemical processes.
The next issues considered are the measurement objective and
signal usage, two relted concepts. Several years ago,
Somogyi, realizing that the quantity measured is not
always the response (signal) from a detector, introduced
the concept of the ’measurement objective’ [6]. The
measurement objective is the quantity measured and used
to compute concentration, activity or any other property
of interest. In most quantitative determinations, the
measurement objective is the detector signal which is used
in some way to calculate concentration, activity etc.
However, in some quantitative determinations such as
titrations and variable-time kinetic methods [7], detector
signal is used only as an indicator that some events (for
example equivalence point in a titration) have occurred.
Some other property, such as volume of titrant in a
titration, or time interval in a variable-time kinetic
method, is used to compute concentration, activity etc.
The situation is reversed in qualitative determinations. In
most qualitative determinations, the measurement objec-
tive is usually the position (for example wavelength or
retention time) of a response rather than the amplitude
of the signal. Signal amplitudes are useful, but are not
the primary measurement objectives. The term measure-
ment objective was coined as a result ofSomogyi’s interest
[6] in what later were called variable-time kinetic
methods [7]; it conveys a concept that is very useful for
contemporary clinical chemistry.
The last issue included in figure 7 relates to the type of
property measured; that is, is it spontaneous (for example
electrochemical potential) or induced (fluorescence, elec-
trolysis current etc.). This feature influences the nature
of instrumentation required. Those approaches that
involvespontaneous responses require only measurement
circuitry; those that involve induced responses also require
sources to induce the processes (for example fluorescence)
that lead to measurable responses. There are, of course,
other issues, such as destructive versus non-destructive
approaches. However, those features included should be
sufficient to illustrate the concepts at this level.
Lower levels (kinetic methods)
Because one of the authors has devoted a lot of effort to
organizing kinetic approaches, this has been chosen to
illustrate lower levels ofoperational approaches (figure 8).
The first issue listed is the general shape of the response curve.
Most procedures identified as kinetic methods involve
unidirectional responses (figure 9[A]). However, there are
many kinetic (transient) responses that are not unidirec-
tional. The most common are bidirectional (peak-shaped)
responses (figure 9[B]) obtained from flow systems, such
as both segmented and unsegmented sample processors,
chromatographic systems and responses from some
chemical reactions that produce unstable products [8].
All of these different responses are transient in nature and
methods based on them are properly classified as kinetic
methods.
The second issue involves variable dependencies. It is
generally recognized that kinetic-based methods depend
more on experimental variables than equilibrium-based
methods [9]. Most methods in common use cannot
compensate for these variable dependencies; these have
been identified as methods without error compensation [10].
However, the literature contains many reports of a wide
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KINETIC METHODS
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Figure 8. Lower level operational approaches to the measurement
function, kinetic methodf.
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variety of methods designed specially to compensate for
such dependencies [ 10-13]. Some of these approaches are
applicable only to unidirectional signals; others are
applicable to both unidirectional and bidirectional
signals. This ability to compensate for changes in
experimental variables, or lack thereof, is one of the most
important features of kinetic methods.
The third issue, analyte selection, relates to whether methods
are designed to quantify only one or more than one
component from a single response. Although most kinetic
methods are designed for single components, many
different multicomponent procedures have been described
in the literature [10 and 13]. Many different computa-
tional approaches have been described; most of them can
be grouped according to whether concentration, activity
etc., is computed directly from the measured signal, or is
computed indirectly by approaches such as curve-fitting
and/or extrapolation methods [10]. Direct-computation
methods usually require detailed knowledge of kinetic
behavior; indirect curve-fitting methods tend to be more
flexible.
Response signals are manipulated in a variety of ways.
One approach is to use the signal without modification; an
example is to use signals measured at two points in time
to compute the change over a fixed time period. A second
approach is to modify the signal in some way. Examples are
to compute the rate of change with time or to compute
the integral of signals versus time. Options involving
unmodified signals were most popular before the advent of
readily available digital computers; options involving
modified signals have become more popular as digital
computers have become more readily available.
Data density is another issue. Characteristics of methods
depend very much upon whether one, two or three or
more data points are used [7].
Many other issues could be considered. However, this
paper is not intended to provide a full understanding of
all these aspects of kinetic methods, but, rather, to identify
some of the types of issues that must be considered in
lower levels of operational options. These and other
aspects of kinetic methods are discussed in more detail in
recent reviews [10-13-1 and references cited therein; in
particular, these papers contain tables and related
discussions in the reviews organize and extend the topics
in figure 8 in much more detail.
Discussion
Time
Figure 9. Illustration of two general types of transient responses
j)equently found in clinical instrumentation.
It is very difficult to master a discipline as diverse and
complex as clinical chemistry without some sort of
systematic approach. The systematic approach has several
attractive features. It differentiates clearly between
functional processes that change very little with time, and
operational approaches to these processes that tend to
change rapidly with time. As such, it provides a stable
infrastructure for the discipline that can be used in a
variety of ways.
The systematic approach is versatile in the sense that it
is applicable to virtually any aspect of the discipline.
Topics emphasized in this paper reflect the Federation’s
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interest in analytical systems used in the service component
ofthe discipline. The research, development, management
and education functions can also be subdivided into
functional and operational components. Similarly, any
one more interested in disease states than in analytical
systems could organize the formulation and testing of
diagnoses (see figure 2) into hierarchical levels of
functional and operational components, as was done here
for parts of the determination function.
The approach offers a way to dispel misconceptions that
many have of the discipline of clinical chemistry. Many
view the clinical laboratory solely as a place where samples
go in and numerical data come out; many confuse the
role of the clinical chemist with that of a technologist or
technician. Many fail to understanding the need for
continued research and education in the area. This is
reflected in the fact that few countries have funding
agencies with funds targeted specifically for research in
clinical chemistry; also, very few academic institutions
have educational programmes in clinical chemistry. The
systematic approach proposed here can be used to
demonstrate the consistencies between this and other
scientific disciplines and the need .for similar kinds of
support.
This approach can be used, as illustrated in figure 2, to
emphasize the interactive nature of the roles of medical
and laboratory personnel, and to differentiate more
clearly than has been done in the past between the roles
of clinical scientists and laboratory technicians. It can
help to tbrmalize more active roles of clinical scientists in
the diagnostic process, without undermining the roles of
medical personnel. For example, referring to figure 2, the
dashed line from the determination step to the testing step
tbr a tentative diagnosis reflects the fact that most clinical
scientists have the background and ability to interpret
data and determine whether tentative diagnoses are valid,
and whether additional data or alternative diagnoses are
indicated. Clinical scientists with the freedom to exercise
such judgements would be .able to provide high-level
intbrmation rather than just data. This could serve the
interests of both medical personnel and their patients.
The infrastructure that is inherent in the approach
proposed here can be useful in many ways. If one is
concerned about issues such as management, quality
assurance or safety, a well-conceived and organized
infrastructure can help identify those areas that need
attention and avoid overlooking important areas that
might result from a less systematic approach. A well-
organized infrastructure can help to identit the areas of
the discipline in which new technologies will have their
major impacts. For example, robotics will likely have its
greatest impact on the sample-processing function (see
figure 3). Artificial intelligence and expert systems, while
having the potential to improve many aspects of instru-
ment systems, have their most apparent impact on the
diagnostic process by providing diagnotic pointers and
suggesting additional information requirements and thus
implementing the cyclic processes represented by figure 2.
A well-conceived infrastructure can be a tremendous aid
to the education process by providing students with a
well-organized structure for the learning process and by
providing correlations among different topics studied. For
example in the traditional approach to the study of
analytical systems, analytical methods are treated more
as a random collection of discrete techniques than as a
well-organized pattern of interrelated concepts and
approaches. This is reflected in the widespread use of
terms such as calorimetric methods, spectrophotometric
methods, enzymatic methods, kinetic methods, liquid
chromatographic methods etc. Each ofthese names focuses
on just one of several critical parts of every method
mentioned. As illustrated in figures 3 and 4, all of these
’methods’ consist of several functional processes. Simplis-
tic names, such as liquid chromatographic methods and
kinetic methods, although containing useful information,
are misleading because virtually all liquid chromato-
graphic methods involve transient responses and accord-
ingly are kinetic-based methods. Use of these simplistic
names obscures correlations and similarities among the
different methods that could greatly reduce the amounts
ofseemingly unrelated facts that students must remember.
At a more advanced level, failure to recognize similarities
such as those covered in figure 7 can represent a barrier to
the extension of technical advances made in one area to
other related areas. For example it has been demonstrated
recently that error-compensating approaches developed
for chemical kinetic processes can be adapted with similar
advantages to physico-chemical processes such as electrode
responses, flow systems and chromatographic signals.
Rather than viewing so-called ’biosensors’ [14-1 as some
sort of isolated, unique device, the systematic approach
leads one to think of these devices as conventional types
of detectors with chemical reactions forced to proceed in
highly localized areas near their surfaces. This realization
leads one to expect that measurement/data-processing
approaches used .to reduce variable dependencies and
extend linear ranges for analogous reactions in homo-
geneous solution can be used to achieve similar advantages
with ’biosensors’. In short, the systematic approach can
change the way one thinks about analytical systems and
other parts of the clinical processes; it forces and helps
one to dissect every process into its component parts and
to relate those parts to their counterparts in other
seemingly unrelated processes.
The black-box syndrome that is afflicting many in the
discipline of clinical chemistry has been described. As
analytical systems have become more highly integrated,
the internal functions have become increasingly difficult
tbr students and clinical scientists to understand. Virtually
all of these systems are designed to implement the
functions in figures 3 and 4 by using operational
approaches such as those in figures 5-8. Accordingly, such
a systematic approach should be useful to manufacturers
who wish to describe their systems more completely, and
to users of these systems who wish to understand them
better. In each case, this approach provides a mechanism
for a systematic way to describe and understand the
different parts of complex systems.
Properly applied, the systems approach can improve
communication in the area by encouraging terms which
convey intended meanings. All too often, terms that do
not mean what is intended are coined and popularized.
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’Random access’, for example, although successfully
marketed, does not convey the intended meaning.
Another pair of terms that does not convey the intended
meaning is heterogeneous’ and ’homogeneous’ immuno-
assays. The correct meanings of these terms are very
different than the intended meanings, namely immuno-
assays that do and do not involve separations. Immuno-
assays that involve a physical separation step are clearly
heterogeneous; however, some immunoassays that do not
require a separation step also have heterogeneous charac-
ter. There are many such examples of poorly conceived
terms that become accepted because they are never tested
critically for their true meanings or consistency. Careful
application of the systems approach as described herein
should help those who coin terms to select terms that
convey intended meanings.
Most of all, this systems approach should help to place the
scientific and professional aspects of the discipline in
proper perspective with its oierational and technological
aspects. Time, space, and other limitations have forcced
this paper to focus on some very limited aspects of the
total system. However, it is hoped that this effort will
inspire those with greater expertise in other areas, such
as the formulation and testing of diagnoses or the use of
diagnostic decision points, to develop aspects ofthe system
that were not included here or to expand and improve
upon those areas discussed above.
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